1. Home
  2. SNGX vs MSN Comparison

SNGX vs MSN Comparison

Compare SNGX & MSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • MSN
  • Stock Information
  • Founded
  • SNGX 1987
  • MSN 1948
  • Country
  • SNGX United States
  • MSN United States
  • Employees
  • SNGX N/A
  • MSN N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • MSN Consumer Electronics/Appliances
  • Sector
  • SNGX Health Care
  • MSN Consumer Staples
  • Exchange
  • SNGX Nasdaq
  • MSN Nasdaq
  • Market Cap
  • SNGX 6.5M
  • MSN 7.5M
  • IPO Year
  • SNGX 1987
  • MSN 1994
  • Fundamental
  • Price
  • SNGX $1.28
  • MSN $0.39
  • Analyst Decision
  • SNGX
  • MSN
  • Analyst Count
  • SNGX 0
  • MSN 0
  • Target Price
  • SNGX N/A
  • MSN N/A
  • AVG Volume (30 Days)
  • SNGX 2.7M
  • MSN 27.6K
  • Earning Date
  • SNGX 08-08-2025
  • MSN 08-13-2025
  • Dividend Yield
  • SNGX N/A
  • MSN N/A
  • EPS Growth
  • SNGX N/A
  • MSN N/A
  • EPS
  • SNGX N/A
  • MSN N/A
  • Revenue
  • SNGX $2,342.00
  • MSN $10,785,000.00
  • Revenue This Year
  • SNGX N/A
  • MSN N/A
  • Revenue Next Year
  • SNGX N/A
  • MSN N/A
  • P/E Ratio
  • SNGX N/A
  • MSN N/A
  • Revenue Growth
  • SNGX N/A
  • MSN 18.91
  • 52 Week Low
  • SNGX $1.09
  • MSN $0.28
  • 52 Week High
  • SNGX $8.55
  • MSN $0.83
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 34.55
  • MSN 51.54
  • Support Level
  • SNGX $1.09
  • MSN $0.36
  • Resistance Level
  • SNGX $1.88
  • MSN $0.42
  • Average True Range (ATR)
  • SNGX 0.14
  • MSN 0.04
  • MACD
  • SNGX -0.01
  • MSN 0.00
  • Stochastic Oscillator
  • SNGX 22.78
  • MSN 79.64

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About MSN Emerson Radio Corporation

Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. The products offered by the company are televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products.

Share on Social Networks: